—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Grifols S.A. (GRF.MC) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 51 out of 100 (momentum 76 · quality 45 · valuation 75), as of 2026-11-04.
  • Signal: Bullish stack, 200-day still turning — Trades +12.7% vs the 50-day and +16.2% vs the 200-day average, 3.3% below the 52-week high and +34.2% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes. (as of 2026-11-03)
  • Trend: Grifols S.A. trades 12.7% above its 50-day and 16.2% above its 200-day moving average. (as of 2026-11-03)

Grifols researches, produces and sells medicines made from human plasma, along with diagnostic testing equipment and hospital supplies. It runs through segments covering biopharma, diagnostics, bio supplies for other manufacturers, and hospital and laboratory services.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GRF.MC overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Bullish stack, 200-day still turning

Trades +12.7% vs the 50-day and +16.2% vs the 200-day average, 3.3% below the 52-week high and +34.2% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the GRF.MC chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on GRF.MC?

Bullish stack, 200-day still turning — Trades +12.7% vs the 50-day and +16.2% vs the 200-day average, 3.3% below the 52-week high and +34.2% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is GRF.MC above its 50-day and 200-day moving averages?

As of 2026-11-03, Grifols S.A. trades +12.7% above its 50-day and +16.2% above its 200-day average, with the 20-day +9.1% away.

How far is GRF.MC from its 52-week high?

3.3% below the 52-week high and 34.2% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.